The failure rate for the approval of new drugs is bad, everyone knows that. But it may be worse than most everyone thought, writes Derek Lowe, who summarizes the latest data on drug success rates in the blog Corante.
...and receive Daily News bulletins.
Already have an account?Login Now.
The Atlantic reports that genetic counselors are coping with an influx of patients seeking advice on their direct-to-consumer genetic test results.
A small study finds differences between three genomic prostate cancer tests, Medscape reports.
In Nature this week: shared genetic architecture for asthma and allergic diseases, and more.
A survey of Canadians finds them to be divided on genetically modified food, the Ottawa Citizen reports.